[HTML][HTML] Immunohistochemistry for pathologists: protocols, pitfalls, and tips
SW Kim, J Roh, CS Park - Journal of pathology and …, 2016 - synapse.koreamed.org
Immunohistochemistry (IHC) is an important auxiliary method for pathologists in routine
diagnostic work as well as in basic and clinical research including exploration of biomarkers …
diagnostic work as well as in basic and clinical research including exploration of biomarkers …
The prognostic value of pre-operative and post-operative B-type natriuretic peptides in patients undergoing noncardiac surgery: B-type natriuretic peptide and N …
Objectives: The objective of this study was to determine whether measuring post-operative B-
type natriuretic peptides (NPs)(ie, B-type natriuretic peptide [BNP] and N-terminal fragment …
type natriuretic peptides (NPs)(ie, B-type natriuretic peptide [BNP] and N-terminal fragment …
Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study
JK Sicklick, S Kato, R Okamura, M Schwaederle… - Nature medicine, 2019 - nature.com
Cancer treatments have evolved from indiscriminate cytotoxic agents to selective genome-
and immune-targeted drugs that have transformed the outcomes of some malignancies …
and immune-targeted drugs that have transformed the outcomes of some malignancies …
OptimalCutpoints: an R package for selecting optimal cutpoints in diagnostic tests
M López-Ratón, MX Rodríguez-Álvarez… - Journal of statistical …, 2014 - jstatsoft.org
Continuous diagnostic tests are often used for discriminating between healthy and diseased
populations. For the clinical application of such tests, it is useful to select a cutpoint or …
populations. For the clinical application of such tests, it is useful to select a cutpoint or …
Cutoff Finder: a comprehensive and straightforward Web application enabling rapid biomarker cutoff optimization
Gene or protein expression data are usually represented by metric or at least ordinal
variables. In order to translate a continuous variable into a clinical decision, it is necessary to …
variables. In order to translate a continuous variable into a clinical decision, it is necessary to …
Methylprednisolone in patients undergoing cardiopulmonary bypass (SIRS): a randomised, double-blind, placebo-controlled trial
RP Whitlock, PJ Devereaux, KH Teoh, A Lamy… - The Lancet, 2015 - thelancet.com
Background Cardiopulmonary bypass initiates a systemic inflammatory response syndrome
that is associated with postoperative morbidity and mortality. Steroids suppress inflammatory …
that is associated with postoperative morbidity and mortality. Steroids suppress inflammatory …
X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization
RL Camp, M Dolled-Filhart, DL Rimm - Clinical cancer research, 2004 - AACR
The ability to parse tumors into subsets based on biomarker expression has many clinical
applications; however, there is no global way to visualize the best cut-points for creating …
applications; however, there is no global way to visualize the best cut-points for creating …
PrognoScan: a new database for meta-analysis of the prognostic value of genes
Background In cancer research, the association between a gene and clinical outcome
suggests the underlying etiology of the disease and consequently can motivate further …
suggests the underlying etiology of the disease and consequently can motivate further …
Interferon-alfa as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma
PURPOSE: To define outcome data and prognostic criteria for patients with metastatic renal
cell carcinoma (RCC) treated with interferon-alfa as initial systemic therapy. The data can be …
cell carcinoma (RCC) treated with interferon-alfa as initial systemic therapy. The data can be …
Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma
RJ Motzer, M Mazumdar, J Bacik, W Berg… - Journal of clinical …, 1999 - ascopubs.org
PURPOSE: To identify prognostic factors and a model predictive for survival in patients with
metastatic renal-cell carcinoma (RCC). PATIENTS AND METHODS: The relationship …
metastatic renal-cell carcinoma (RCC). PATIENTS AND METHODS: The relationship …